Upping Your Game: Episode 1 – Meeting Hui Chen’s Challenge
SBR – Author’s Podcast: Understanding Complexity with Dr. Jean Boulton, Part 1: Ethics, Compliance, and Organizational Dynamics
Innovation in Compliance: Exploring the Fractional COO Model with La Tonya Roberts
Daily Compliance News: April 29, 2025, The GenZ/RTO Edition
Adventures in Compliance: The Novels – A Study in Scarlet, Introduction to Compliance Lessons
FCPA Compliance Report: From Compliance to Commercial Value: Removing Friction with AI
Compliance Tip Of the Day: Using AI to Transform Whistleblower Response
Because That’s What Heroes Do: Deep Space 9 – Episode 30: Deep Trek Themes from Tacking into the Wind
Compliance Tip of the Day: The Future of Continuous Monitoring
FCPA Compliance Report: Ellen Hunt on Compliance ROI and on a Due Diligence and the US Sentencing Guidelines
Compliance and AI: Transforming Compliance Through AI with Marcelo Erthal
Breaking Down the Shifting Vaccine Policy Landscape – Diagnosing Health Care Video Podcast
Compliance Tip of the Day: Leveraging AI for Real-Time Third-Party Risk Management
FCPA Compliance Report: Amanda Carty on a Due Diligence and Risk Management
Innovation in Compliance: Design-Centric Compliance Training with Karen Oddo
Compliance Tip of the Day: AI and Predictive Analytics
FCPA Compliance Report: Kristy Grant-Hart on A 360° Review of the Future of Compliance
Great Women in Compliance: Creating Space to Speak Up: The Story Behind Psst.org
Daily Compliance News: April 23, 2025, The R-E-S-P-E-C-T Edition
Aligning Business Goals with Legal Strategies Amid Regulatory Change – Speaking of Litigation Video Podcast
Digital transformation in the financial services sector is no longer a future aspiration; it is a current reality. The global financial ecosystem is undergoing an exponential evolution, spurred by advances in artificial...more
Welcome to Multidimensional Data Reversion, a four-part podcast series from Ropes & Gray’s Insights Lab where data analysis intersects with the law. On this first episode, join Shannon Capone Kirk, managing principal and...more
The immigration law world moves fast, professionals face constant pressure to manage complex cases, track regulations, and deliver accurate results under tight deadlines....more
Artificial intelligence (AI), particularly generative AI, thrives on vast amounts of data, fueling AI capabilities, insights, and predictions. But with this reliance on data comes potential privacy and security risks. And...more
Over the last six years, investment management professionals have steadily increased their use of alternative data to improve decision-making, optimize portfolios, improve due diligence, and boost returns. Now, with widely...more
As law firms face mounting pressure to increase efficiency while maintaining accuracy, artificial intelligence is emerging as a game-changing solution in court reporting. This article explores how AI-powered digital reporting...more
This article outlines the stages of CLM maturity and how Artificial Intelligence (AI) can be strategically integrated at each level to drive efficiency, reduce risk, and maximize business value. The Epiq CLM Maturity Model...more
In 2025, technology holds a well-established place in the legal profession. And even though there are headlines about emerging tech itself being on trial, the pros of Artificial Intelligence (AI), Machine Learning (ML), and...more
Recently, while preparing for an upcoming panel presentation at the ASU Arkfeld eDiscovery, Law and Technology Conference on March 11 and 12 (Learn more about the conference HERE), my co-panelists and I were discussing...more
Imagine searching for a crucial conversation in a sea of endless chat messages—messages filled with greetings, status updates, and casual banter. The reality of modern enterprise communication is an overwhelming flood of...more
In the digital age, managing data is a critical task. Especially when it comes to legal and compliance matters. Enter eDiscovery in Office 365. This powerful tool helps organizations search, locate, and secure data...more
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial intelligence (AI): Artificial Intelligence-Enabled Device Software Functions: Lifecycle...more
The 2025 SCOPE Conference (Summit for Clinical Ops Executives), held last week in Orlando, FL, brought together more than 4,500 industry leaders, innovators, and experts in the clinical operations field. ...more
Generative AI is quickly transforming many industries—including legal services. Many of us are already using (or at least experimenting with) Generative AI, with impressive results. Allow me to introduce the next leg in our...more
As law firms and legal departments race to leverage artificial intelligence for competitive advantage, many are contemplating the development of private Large Language Models (LLMs) trained on their work product. While the...more
A Strategic Guide for Legal Departments to Optimize Their Technology Stack and Drive Efficiency in 2025 - The start of a new year brings a fresh opportunity to take stock of what’s working and what’s not – especially when...more
Your perspectives and perceptions towards a problem drive your approach to solving that problem. Managing data privacy challenges are no different. Therefore, to address today’s issues, it is a worthwhile exercise to review...more
In the early days of first-generation AI models, legal industry technology providers did not frequently encounter the question, “Where do my models live?” The assumption has always been that the models live where the data...more
The Food and Drug Administration (FDA) has recently issued two draft guidance documents aimed at providing recommendations for the use of AI in medical devices and drug and biological product development.These guidance...more
On January 7, 2025, the Food and Drug Administration (FDA) made available a draft guidance for industry (GFI) titled “Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and...more
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s safety, effectiveness, or...more
On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations,” which...more
On January 7, 2025, FDA published “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff”...more
Generative Artificial Intelligence (Gen AI) is transforming industries at an unprecedented pace, unlocking new possibilities in automation, creativity, and problem-solving. However, as we look toward 2025, the success and...more
The rapid rise of artificial intelligence (“AI”) is reshaping industries, transforming economies, and presenting profound legal and ethical challenges....more